التفاصيل البيبلوغرافية
| العنوان: |
Development and validation of machine learning model for predicting treatment responders in patients with primary biliary cholangitis. |
| المؤلفون: |
Kimura, Naruhiro, Takahashi, Kazuya, Setsu, Toru, Horibata, Yusuke, Kaneko, Yusuke, Miyazaki, Haruka, Ogawa, Kohei, Kawata, Yuzo, Sakai, Norihiro, Watanabe, Yusuke, Abe, Hiroyuki, Kamimura, Hiroteru, Sakamaki, Akira, Yokoo, Takeshi, Kamimura, Kenya, Tsuchiya, Atsunori, Terai, Shuji |
| المصدر: |
Hepatology Research; Jan2024, Vol. 54 Issue 1, p67-77, 11p |
| مصطلحات موضوعية: |
MACHINE learning, CHOLANGITIS, URSODEOXYCHOLIC acid, ALKALINE phosphatase, ALANINE aminotransferase |
| مستخلص: |
Aims: Ursodeoxycholic acid is the first‐line treatment for primary biliary cholangitis, and treatment response is one of the factors predicting the outcome. To prescribe alternative therapies, clinicians might need additional information before deciphering the treatment response to ursodeoxycholic acid, contributing to a better patient prognosis. In this study, we developed and validated machine learning (ML) algorithms to predict treatment responses using pretreatment data. Methods: This multicenter cohort study included collecting datasets from two data samples. Data 1 included 245 patients from 18 hospitals for ML development, and was divided into (i) training and (ii) development sets. Data 2 (iii: test set) included 51 patients from our hospital for validation. An extreme gradient boosted tree predicted the treatment response in the ML model. The area under the curve was used to evaluate the efficacy of the algorithm. Results: Data 1 showed that patients complying with the Paris II treatment response had significantly lower serum alkaline phosphatase and total bilirubin levels than those who did not respond. Three factors, total bilirubin, total protein, and alanine aminotransferase levels were selected as essential variables for prediction. Data 2 showed that patients complying with the Paris II criteria had significantly high prothrombin time and low total bilirubin levels. The area under the curve of extreme gradient boosted tree was good for (ii) (0.811) and (iii) (0.856). Conclusions: We demonstrated the efficacy of ML in predicting the treatment response for patients with primary biliary cholangitis. Early identification of cases requiring additional treatment with our novel ML model may improve prognosis. [ABSTRACT FROM AUTHOR] |
|
Copyright of Hepatology Research is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
